Impact of Baseline Cardiogenic Shock Severity on Outcomes in Patients Treated With Impella Device
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.043266 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Hiroaki Yokoyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Tokushima Red Cross Hospital Tokushima Japan. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Heart-Assist Devices. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Risk stratification of patients with cardiogenic shock (CS) is of considerable importance. We aimed to test the utility of the Society for Cardiovascular Angiography and Intervention shock staging system recently refined by the CS Working Group in an Asian population and to investigate its association with in‐hospital adverse events.
Methods
From the Japanese nationwide registry of Impella, the patients with CS who successfully received Impella support between February 2020 and December 2023 were included and assigned to any stage according to the CS Working Group–refined Society for Cardiovascular Angiography and Intervention staging system. We set the primary end point as in‐hospital death and explored it within each stage, with stage B as a reference.
Results
In total, 4643 patients were analyzed (median age, 69 years; women, 23.3%; CS due to acute myocardial infarction, 61.7%), and 122, 588, 1905, and 2058 patients were in stages B, C, D, and E, respectively. After adjustment with potential confounders, stage C had no significant difference in in‐hospital death (odds ratio, 1.12 [95% CI, 0.69–1.80]; P =0.653). However, with adjusted analysis, stages D and E had a significantly higher rate of in‐hospital death (stage D: odds ratio, 2.41 [95% CI, 1.55–3.77]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology Tokushima Red Cross Hospital Tokushima Japan.
- Department of Cardiovascular Medicine Tokushima University Graduate School of Biomedical Sciences Tokushima Japan.
ORCID-Profile: Hiroaki Yokoyama, Shinobu Hosokawa, Masataka Sata
Zitieren
APA
Yokoyama, H., Hosokawa, S., Sata, M., Kishi, K., & J‐PVAD Investigators (2025). Impact of Baseline Cardiogenic Shock Severity on Outcomes in Patients Treated With Impella Device. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.043266
Vancouver
Yokoyama H, Hosokawa S, Sata M, Kishi K, J‐PVAD Investigators. Impact of Baseline Cardiogenic Shock Severity on Outcomes in Patients Treated With Impella Device. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.043266
BibTeX
@article{Yokoyama2025,
author = {Yokoyama, Hiroaki and Hosokawa, Shinobu and Sata, Masataka and Kishi, Koichi and J‐PVAD Investigators, J‐PVAD Investigators},
title = {Impact of Baseline Cardiogenic Shock Severity on Outcomes in Patients Treated With Impella Device},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.043266}
}
EUVIMED